Diabetic foot ulceration is one of the most common complications in patients treated for diabetes mellitus. The presented pilot study describes the successful treatment of diabetic ulceration of the heel with ongoing osteomyelitis in a 39-year-old patient after using a combination of modified chitosan-based biomaterial in combination with autologous mesenchymal stem cells isolated from bone marrow and dermal fibroblasts. The isolated population of bone marrow mesenchymal stem cells fulfilled all of the attributes given by the International Society for Stem Cell Research, such as fibroblast-like morphology, the high expression of positive surface markers (CD29: 99.1 ± 0.4%; CD44: 99.8 ± 0.2% and CD90: 98.0 ± 0.6%) and the ability to undergo multilineage differentiation. Likewise, the population of dermal fibroblasts showed high positivity for the widely accepted markers collagen I, collagen III and vimentin, which was confirmed by immunocytochemical staining. Moreover, we were able to describe newly formed blood vessels shown by angio CT and almost complete closure of the skin defect after 8 months of the treatment.

Accurate documentation of burn wounds is essential for evaluating treatment outcomes and monitoring healing progression. Traditional two-dimensional (2D) photography remains the clinical standard but lacks depth and volumetric accuracy. Three-dimensional (3D) scanning offers enhanced visualization of wound morphology and tissue vitality, potentially improving objectivity in burn assessment. This study compares two handheld 3D scanning systems—Artec Eva and Revopoint Miraco—in documenting acute and healing burn wounds, using standard clinical photography as the reference. Fifteen patients with second-degree and third-degree burns were prospectively examined at the Burn Unit of AGEL Hospital Košice-Šaca, with five representative cases selected for detailed analysis. For each patient, clinical photographs and paired 3D scans were obtained under standardized conditions and evaluated for color fidelity, wound margin clarity, representation of epithelialisation islands, necrotic tissue, and correlation with clinical findings. Across all cases, Artec Eva demonstrated superior color accuracy, clearer wound delineation, and more realistic visualization of tissue vitality and re-epithelialisation. Revopoint Miraco reliably captured wound shape but produced darker tones and exaggerated surface relief, occasionally distorting depth perception. Overall, both systems successfully identified key healing features; however, Artec Eva provided more clinically accurate and visually consistent results. Three-dimensional scanning represents a valuable adjunct to conventional burn documentation.

Background: Burn assessment traditionally relies on visual inspection and 2D estimation, which introduces substantial variability in determining wound size and healing progression. Three-dimensional (3D) surface scanning offers a more objective alternative, yet the clinical utility of area-based metrics obtained from 3D surface data remains insufficiently defined. This pilot study aimed to evaluate structured-light 3D scanning for objective longitudinal quantification of the burn wound surface area and a description of area-based healing dynamics derived from repeated measurements. Methods: Eighteen patients with 43 acute thermal burns underwent serial structured-light scanning, followed by manual segmentation of wound regions and the calculation of absolute and percentage area reduction as well as TBSA-normalized metrics. Longitudinal monitoring was performed by comparing sequential 3D surface models acquired at defined clinical follow-ups, enabling the calculation of absolute area change (ΔA), percentage reduction, daily healing rate, and ΔTBSA%. Results: Baseline wound areas ranged from 7.27 to 2137.98 cm². Percentage area reduction ranged from 5.25% to 92.30%. The overall reduction in burn burden (ΔTBSA) ranged from 0.07% to 12.94%. Large wounds tended to show rapid absolute area reduction (>100–300 cm²/day) during early follow-up, while small superficial burns frequently achieved >80% reduction within 10–15 days. Conclusions: These findings suggest that 3D surface scanning may support the objective longitudinal assessment of burn wound healing. This pilot provides a basis for future studies evaluating additional topographic parameters and broader clinical applications.

Background: Calciphylaxis (calcific uremic arteriolopathy), is a rare disease characterized by subcutaneous vascular thrombosis and necrotic skin lesions, which mainly affects patients with kidney disease. This condition often has a poor prognosis, unclear pathophysiology, and lacks standardized treatment. Case Description: We present a case of calciphylaxis in a 53-year-old female patient who reported gradually worsening unbearable pain in her lower limbs and thighs, persisting for approximately 18 months. After appropriate examinations and biopsy of non-healing wounds, histopathology confirmed the diagnosis of calciphylaxis. The wounds were treated with dermo-epidermal (DE) grafts. Followingly, the patient underwent treatment in a hyperbaric chamber, after which the wounds decreased in size. Conclusions: Early diagnosis and a comprehensive approach to therapy are necessary to improve the management of calcification, a rare disease, and complications such as non-healing wounds.

Background: Hypertrophic scarring remains a common and clinically challenging consequence of burn injury. Although compression therapy is widely used, its effectiveness is limited by variability in pressure delivery, lack of personalization and inconsistent treatment protocols. Methods: This prospective single-centre feasibility study included adult patients with post-burn scars following deep partial-thickness or full-thickness injuries. The study was designed as a two-phase workflow. In Phase I, scars were documented using standardized photography and 3D surface scanning and were evaluated using the Vancouver Scar Scale (VSS). Scars were stratified based on a predefined threshold (VSS >6) for progression to intervention. In Phase II, patient-specific compression matrices will be designed from 3D surface data and fabricated using biocompatible material. Computational modeling using finite element analysis (FEA) will be applied to simulate pressure distribution. Follow-up is planned at 1, 3, and 6 months, with the VSS as the primary outcome measure. Results: A total of 27 scars were included. The median VSS score was 7 (IQR 5–8). Based on stratification, 14 scars (51.9%) were eligible for personalized compression therapy. Three-dimensional imaging was feasible in all cases and allowed for improved qualitative visualization of scar morphology compared to standard photography. Preliminary findings support the applicability of the proposed workflow, while longitudinal outcome analysis is ongoing. Conclusions: This feasibility study presents and evaluates a clinical workflow combining 3D imaging, objective scar stratification, and personalized compression therapy. This approach provides a structured framework for personalized compression therapy, while its clinical effectiveness remains to be established. Further studies are required to evaluate long-term outcomes.